Soleus Capital Management as of March 31, 2021
Portfolio Holdings for Soleus Capital Management
Soleus Capital Management holds 72 positions in its portfolio as reported in the March 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Bioatla (BCAB) | 29.1 | $162M | 3.2M | 50.84 | |
Essa Pharma Com New (EPIX) | 10.8 | $60M | 2.1M | 29.05 | |
Theratechnologies | 4.8 | $27M | 7.0M | 3.87 | |
Iveric Bio | 3.8 | $21M | 3.4M | 6.18 | |
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 3.7 | $21M | 967k | 21.37 | |
C4 Therapeutics Com Stk (CCCC) | 3.1 | $17M | 464k | 36.99 | |
Krystal Biotech (KRYS) | 2.3 | $13M | 167k | 77.04 | |
Astrazeneca Sponsored Adr (AZN) | 2.3 | $13M | 258k | 49.72 | |
Xenon Pharmaceuticals (XENE) | 2.3 | $13M | 708k | 17.90 | |
Iradimed (IRMD) | 2.2 | $12M | 482k | 25.77 | |
Vesper Healthcare Acqstn Cor Com Cl A | 1.8 | $9.9M | 921k | 10.80 | |
Galecto (GLTO) | 1.7 | $9.2M | 1.5M | 6.07 | |
SurModics (SRDX) | 1.6 | $8.6M | 154k | 56.07 | |
Inhibrx (INBX) | 1.5 | $8.1M | 402k | 20.07 | |
Natera (NTRA) | 1.4 | $7.9M | 78k | 101.53 | |
Itamar Med Sponsored Ads | 1.2 | $6.5M | 270k | 23.95 | |
Misonix | 1.1 | $5.9M | 301k | 19.59 | |
Vaxcyte (PCVX) | 1.0 | $5.8M | 294k | 19.75 | |
Lyra Therapeutics (LYRA) | 1.0 | $5.5M | 476k | 11.59 | |
Assembly Biosciences | 0.9 | $5.2M | 1.1M | 4.60 | |
MiMedx (MDXG) | 0.9 | $5.2M | 500k | 10.30 | |
Flexion Therapeutics | 0.8 | $4.7M | 523k | 8.95 | |
Silverback Therapeutics (SPRY) | 0.8 | $4.2M | 97k | 43.63 | |
Exelixis (EXEL) | 0.7 | $4.1M | 182k | 22.59 | |
Repare Therapeutics Ord (RPTX) | 0.7 | $4.1M | 133k | 30.69 | |
Alexion Pharmaceuticals | 0.7 | $3.9M | 25k | 152.90 | |
Establishment Labs Holdings Ord (ESTA) | 0.7 | $3.8M | 61k | 62.53 | |
4d Molecular Therapeutics In (FDMT) | 0.7 | $3.7M | 86k | 43.38 | |
Cutera (CUTR) | 0.6 | $3.6M | 120k | 30.05 | |
Koninklijke Philips N V Ny Reg Sh New (PHG) | 0.6 | $3.5M | 61k | 57.04 | |
Dariohealth Corp Com New (DRIO) | 0.6 | $3.4M | 179k | 19.26 | |
Rafael Hldgs Com Cl B (RFL) | 0.6 | $3.4M | 86k | 39.92 | |
Kinnate Biopharma (KNTE) | 0.6 | $3.4M | 109k | 31.16 | |
Novocure Ord Shs (NVCR) | 0.6 | $3.3M | 25k | 132.16 | |
Gossamer Bio Note 5.000% 6/0 (Principal) | 0.6 | $3.3M | 3.8M | 0.89 | |
Alpine Immune Sciences (ALPN) | 0.6 | $3.3M | 313k | 10.60 | |
Edgewise Therapeutics (EWTX) | 0.6 | $3.3M | 100k | 32.50 | |
Bridgebio Pharma Note 2.500% 3/1 (Principal) | 0.6 | $3.2M | 2.0M | 1.65 | |
Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.6 | $3.1M | 300k | 10.47 | |
Tcr2 Therapeutics Inc cs | 0.6 | $3.1M | 142k | 22.08 | |
Sientra | 0.5 | $2.8M | 378k | 7.29 | |
Dyne Therapeutics (DYN) | 0.5 | $2.7M | 174k | 15.53 | |
Revolution Medicines (RVMD) | 0.5 | $2.6M | 57k | 45.87 | |
Dex (DXCM) | 0.4 | $2.5M | 6.9k | 359.34 | |
Avidity Biosciences Ord (RNA) | 0.4 | $2.4M | 109k | 21.81 | |
Merck & Co (MRK) | 0.4 | $2.3M | 30k | 77.09 | |
Inari Medical Ord (NARI) | 0.4 | $2.3M | 22k | 106.99 | |
Catabasis Pharmaceuticals In Com New | 0.4 | $2.2M | 775k | 2.89 | |
Neogenomics Com New (NEO) | 0.4 | $2.2M | 46k | 48.23 | |
Edap Tms S A Sponsored Adr (EDAP) | 0.4 | $2.1M | 250k | 8.40 | |
Renalytix Ai Ads (RNLX) | 0.4 | $2.1M | 80k | 25.66 | |
Eiger Biopharmaceuticals | 0.3 | $1.9M | 214k | 8.85 | |
Staar Surgical Com Par $0.01 (STAA) | 0.3 | $1.8M | 17k | 105.39 | |
Compass Pathways Sponsored Ads (CMPS) | 0.3 | $1.6M | 43k | 36.82 | |
Oncocyte | 0.3 | $1.5M | 297k | 5.19 | |
Oak Street Health | 0.3 | $1.5M | 28k | 54.29 | |
Deerfield Healthcare Tech Ac Com Cl A | 0.3 | $1.4M | 119k | 12.12 | |
Morphic Hldg (MORF) | 0.2 | $1.4M | 22k | 63.30 | |
Scholar Rock Hldg Corp (SRRK) | 0.2 | $1.3M | 26k | 50.65 | |
Kadmon Hldgs | 0.2 | $1.3M | 336k | 3.89 | |
Pieris Pharmaceuticals (PIRS) | 0.2 | $1.3M | 500k | 2.57 | |
Magenta Therapeutics | 0.2 | $1.2M | 100k | 11.84 | |
Miragen Therapeutics (VRDN) | 0.2 | $1.1M | 68k | 16.71 | |
Trillium Therapeutics Com New | 0.2 | $1.1M | 104k | 10.74 | |
Kymera Therapeutics (KYMR) | 0.2 | $1.1M | 28k | 38.87 | |
Adverum Biotechnologies | 0.2 | $986k | 100k | 9.86 | |
Oncorus | 0.2 | $929k | 67k | 13.92 | |
Revance Therapeutics (RVNC) | 0.2 | $870k | 31k | 27.94 | |
Mirati Therapeutics | 0.1 | $594k | 3.5k | 171.38 | |
Turning Point Therapeutics I | 0.1 | $528k | 5.6k | 94.67 | |
Hims & Hers Health *w Exp 01/20/202 | 0.1 | $404k | 92k | 4.40 | |
Cardiff Oncology (CRDF) | 0.1 | $395k | 43k | 9.25 |